{
  "doc_id": "Determina_33-2024_Lumykras",
  "created_date": "2024",
  "country": "IT",
  "source_type": "hta_submission",
  "chunks": [
    {
      "heading": "",
      "text": "AG FA DET Ricl dell (Det (OJ Vi corre modi l'Ag disp Serv Vi salu dello sull farm sett nine genn Mini pubblici genn Vi dello pubblica Gazz GENZIA ITALIANA DEL ARMACO TERMINA 17 May 2024 lassification of the medicinal product for human use (Lumykras) pursuant to Article 8 (10) of Law No 537 of 24 December 1993, ending No 33/2024). (24A02603) U No 121 of 25-5-2024)",
      "start_page": 1,
      "end_page": 1
    },
    {
      "heading": "THE CHAIRMAN is Art. 48 of Decree-Law No 269 of 30 September 2003,",
      "text": "20th and 20th centuries of the Italian Civil Service Decree no. 326 of 24 November 2003, which established the Italian Gency of the drug and, in particular, paragraph 33, which places the negotiation of the price for the products reimbursed by the national health service between the Agency and producers; in accordance with Art. 48, paragraph 13, of Decree-Law No. 269 of 30 November 2003, converted, with amendments, by Law No. 326/2003, as last amended by Decree No. 8 January 2024, No. 3 of the Minister of Health, in agreement with the legal instruments of the public service and of the economy and of finance, published in the Official Gazette - General Series - No. 11 of 15 January 2024; I am the regulation of organisation, operation and coordination of the staff of the Agency of the Federal Republic of Italy (the Official Journal No. In the light of Article 48 of the Treaty on the Functioning of the European Union, the Court of Justice has held that, by virtue of the provisions of Council Regulation (EC) No 40/94 of 30 September 2003 on the protection of the health of sports activities and of the fight against doping, the Italian Republic has failed to fulfil its obligations under the Treaty of Accession of the former Yugoslav Republic of Macedonia, the Federal Republic of Yugoslavia, the Republic of Slovenia, the Czech Republic, the Kingdom of Slovenia and the Republic thereof. 2272 of 29 September 2006; In view of the determination of AIFA No 49/2022 of 1 April 2022, published in the Official Journal of the Italian Republic - General Series No 109 of 11 May 2022, bearing the following classification, pursuant to Article 12 (5) of Law No 189 of 8 November 2012, of the medicinal product for human use \"Lumykras\" approved by centralized procedure (sotorasib); in view of an application made by the Technical and Scientific Consultative Commission at its meeting on 2-4 May 2022 and at its session on 3-5 April 2023; in viewof the opinion given by the Committee on prices and reimbursement at its sitting on 12-15 January 2024; in the light of Decision No 10 of 17 April 2024 of the Board of Directors of the AIFA concerning the approval of medicinal products for the purposes of marketing and refundable by the National Health Service; in the absence of the acts of the Office; in decision on the classification of the following medicinal products to the purposes. For the purpose of the prescription and dispensation of the medicinal product, doctors and pharmacists belonging to the user centres specifically identified by the regions will have to complete the computerised data sheet available against access through the institutional website of the AIFA, at the web address The doctors and chemists authorized for access to the monitoring register AIFA shall carry out the prescribing and dispensing of the medicine in accordance with the eligibility criteria and prescriptive appropriateness reported in the documentation available on the institutional portal of the AFA: In case of temporary impediment of access to information systems, the doctors and authorized pharmacists shall ensure the treatment from the date of entry into force of the present Directive (as amended by the provisions of this Directive).",
      "start_page": 1,
      "end_page": 5
    }
  ],
  "_translation_metadata": {
    "processing_timestamp": "2025-08-04T10:34:10.566594",
    "source_file": "Determina_33-2024_Lumykras_cleaned.json",
    "detected_language": "it",
    "was_translation_needed": true,
    "tier_attempts": [
      {
        "tier": 1,
        "model_loaded": true,
        "model_name": "Helsinki-NLP/opus-mt-it-en",
        "processing_time_seconds": 29.018867,
        "chunks_found": true,
        "total_chunks": 2,
        "chunks_translated": 3,
        "chunks_english": 0,
        "table_chunks_processed": 0,
        "quality_scores": {
          "overall": 0.7619532520325203,
          "english_quality": 0.7166666666666667,
          "medical_preservation": 0.8174999999999999,
          "length_appropriateness": 0.7566463414634146,
          "chunk_count": 2
        }
      }
    ],
    "final_tier_used": 1,
    "final_model_used": "Helsinki-NLP/opus-mt-it-en",
    "escalation_occurred": false,
    "quality_comparison": {},
    "final_quality_scores": {
      "overall": 0.7619532520325203,
      "english_quality": 0.7166666666666667,
      "medical_preservation": 0.8174999999999999,
      "length_appropriateness": 0.7566463414634146,
      "chunk_count": 2
    },
    "chunks_translated": 2,
    "chunks_preserved_english": 1,
    "table_chunks_processed": 0,
    "total_processing_time_seconds": 40.067247,
    "translation_strategy": "tier_1_first_direct_translation",
    "quality_assessment": "balanced_weighted_approach",
    "table_content_detected": 0,
    "tier_1_available": true,
    "tier_2_available": true,
    "translation_decision": "tier_1_sufficient",
    "processing_completed_timestamp": "2025-08-04T10:34:50.633847"
  }
}